Veterinary Intravenous (IV) Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image

Sale

Veterinary Intravenous (IV) Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Report
182 Pages
June 2025
Region: Global
TechSci Research
ID: 5895683

UP TO €749EUR$825USD£631GBP OFF until Jul 31^st 2025

The Veterinary Intravenous (IV) Solutions Market was valued at USD 1.35 Billion in 2024, and is expected to reach USD 1.96 Billion by 2030, rising at a CAGR of 6.57%. This growth reflects advancements in veterinary medicine, mirroring trends in human healthcare, where IV solutions are integral to treatment protocols. Veterinary IV solutions are crucial for hydration, medication delivery, and critical care across a variety of animal species.

Increasing global pet ownership, heightened expectations for animal care, and the growing number of insured pets - such as the 6.25 million pets reported insured in North America in 2024 - are major contributors to this surge in demand. These solutions are used in both routine and emergency situations, supporting recovery and treatment efficacy in veterinary settings. As the human-animal bond deepens and pet care becomes more sophisticated, the need for reliable, effective IV therapies continues to grow, driving market expansion worldwide.

Key Market Drivers

Rising Pet Ownership and Humanization is Driving the Global Veterinary Intravenous (IV) Solutions Market

The rapid increase in global pet ownership and the growing trend of treating pets as family members are significantly boosting demand for veterinary healthcare services, including IV solutions. In the U.S., approximately 67% of households own a pet, a trend echoed in many other regions. This humanization of pets has transformed the way owners approach healthcare, prompting greater interest in advanced medical treatments similar to those used for humans. Veterinary IV solutions, vital for administering fluids, medications, and nutrients during critical care, are increasingly in demand as pet owners seek comprehensive and high-quality medical support. The surge in pet insurance coverage also supports this growth by making advanced veterinary treatments more financially accessible, encouraging more pet owners to opt for intensive interventions that include IV therapy.

Key Market Challenges

Limited Research and Formulation Variety Poses a Significant Obstacle To Market Expansion

A significant challenge facing the veterinary IV solutions market is the limited research and formulation diversity tailored to various animal species. Unlike human IV solutions, which benefit from extensive R&D and specificity, veterinary formulations often lack the same level of customization. This is particularly problematic for exotic and less common species that have unique physiological needs not addressed by standard formulations. The limited number of species-specific products restricts veterinarians' ability to deliver optimal care, which can impact treatment outcomes. This gap in product variety hinders market expansion and highlights the need for increased investment in research to develop a broader range of targeted IV solutions across diverse animal categories.

Key Market Trends

Technological Advancements

The integration of precision medicine and digital health technologies is reshaping the veterinary IV solutions market. Diagnostic innovations, such as genetic testing, allow for the formulation of personalized IV therapies, improving treatment effectiveness and patient outcomes. Telemedicine platforms and remote monitoring tools are also revolutionizing care delivery, enabling veterinarians to track patient vitals and modify IV regimens in real time without in-person visits. Moreover, smart infusion pumps and automated delivery systems enhance accuracy and safety by precisely controlling fluid and medication administration. These systems can adapt dosages dynamically based on live data. The adoption of digital health records and analytics further supports data-driven treatment decisions, improving care outcomes and contributing to the evolution of more targeted, efficient, and intelligent veterinary healthcare protocols.

Key Market Players

Merck & Co., Inc.
Dechra Veterinary Products
Sypharma Pty Ltd.
Animalcare group plc
Braun SE
Woods Consulting, LLC
Baxter International
Fresenius Kabi

Report Scope:

In this report, the Global Veterinary Intravenous (IV) Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Intravenous (IV) Solutions Market, By Product:

Isotonic crystalloids
Synthetic colloids
Blood products
Dextrose solutions
Parenteral nutrition

Veterinary Intravenous (IV) Solutions Market, By Indication:

Diabetic Ketoacidosis
Pancreatitis
Anthrax
Chronic Kidney Disease
Others

Veterinary Intravenous (IV) Solutions Market, By Animal Type:

Companion Animals
Production Animals

Veterinary Intravenous (IV) Solutions Market, By End Use:

Veterinary Hospitals
Research Institutes
Others

Veterinary Intravenous (IV) Solutions Market, By Region:

North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Intravenous (IV) Solutions Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Intravenous (IV) Solutions Market Outlook

5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Isotonic crystalloids, Synthetic colloids, Blood products, Dextrose solutions, Parenteral nutrition)
5.2.2. By Indication (Diabetic Ketoacidosis, Pancreatitis, Anthrax, Chronic Kidney Disease, Others)
5.2.3. By Animal type (Companion Animals, Production Animals)
5.2.4. By End Use (Veterinary Hospitals, Research Institutes, Others)
5.2.5. By Region
5.2.6. By Company (Shares of Top 5 Market Players)
5.3. Market Map
5.3.1. By Product
5.3.2. By Indication
5.3.3. By Animal type
5.3.4. By End Use
5.3.5. By Region

6. North America Veterinary Intravenous (IV) Solutions Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Indication
6.2.3. By Animal type
6.2.4. By End Use
6.2.5. By Country
6.2.5.1. United States Veterinary Intravenous (IV) Solutions Market Outlook
6.2.5.1.1. Market Size & Forecast
6.2.5.1.1.1. By Value
6.2.5.1.2. Market Share & Forecast
6.2.5.1.2.1. By Product
6.2.5.1.2.2. By Indication
6.2.5.1.2.3. By Animal type
6.2.5.1.2.4. By End Use
6.2.5.2. Canada Veterinary Intravenous (IV) Solutions Market Outlook
6.2.5.2.1. Market Size & Forecast
6.2.5.2.1.1. By Value
6.2.5.2.2. Market Share & Forecast
6.2.5.2.2.1. By Product
6.2.5.2.2.2. By Indication
6.2.5.2.2.3. By Animal type
6.2.5.2.2.4. By End Use
6.2.5.3. Mexico Veterinary Intravenous (IV) Solutions Market Outlook
6.2.5.3.1. Market Size & Forecast
6.2.5.3.1.1. By Value
6.2.5.3.2. Market Share & Forecast
6.2.5.3.2.1. By Product
6.2.5.3.2.2. By Indication
6.2.5.3.2.3. By Animal type
6.2.5.3.2.4. By End Use

7. Europe Veterinary Intravenous (IV) Solutions Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Indication
7.2.3. By Animal type
7.2.4. By End Use
7.2.5. By Country
7.2.5.1. France Veterinary Intravenous (IV) Solutions Market Outlook
7.2.5.1.1. Market Size & Forecast
7.2.5.1.1.1. By Value
7.2.5.1.2. Market Share & Forecast
7.2.5.1.2.1. By Product
7.2.5.1.2.2. By Indication
7.2.5.1.2.3. By Animal type
7.2.5.1.2.4. By End Use
7.2.5.2. Germany Veterinary Intravenous (IV) Solutions Market Outlook
7.2.5.2.1. Market Size & Forecast
7.2.5.2.1.1. By Value
7.2.5.2.2. Market Share & Forecast
7.2.5.2.2.1. By Product
7.2.5.2.2.2. By Indication
7.2.5.2.2.3. By Animal type
7.2.5.2.2.4. By End Use
7.2.5.3. United Kingdom Veterinary Intravenous (IV) Solutions Market Outlook
7.2.5.3.1. Market Size & Forecast
7.2.5.3.1.1. By Value
7.2.5.3.2. Market Share & Forecast
7.2.5.3.2.1. By Product
7.2.5.3.2.2. By Indication
7.2.5.3.2.3. By Animal type
7.2.5.3.2.4. By End Use
7.2.5.4. Italy Veterinary Intravenous (IV) Solutions Market Outlook
7.2.5.4.1. Market Size & Forecast
7.2.5.4.1.1. By Value
7.2.5.4.2. Market Share & Forecast
7.2.5.4.2.1. By Product
7.2.5.4.2.2. By Indication
7.2.5.4.2.3. By Animal type
7.2.5.4.2.4. By End Use
7.2.5.5. Spain Veterinary Intravenous (IV) Solutions Market Outlook
7.2.5.5.1. Market Size & Forecast
7.2.5.5.1.1. By Value
7.2.5.5.2. Market Share & Forecast
7.2.5.5.2.1. By Product
7.2.5.5.2.2. By Indication
7.2.5.5.2.3. By Animal type
7.2.5.5.2.4. By End Use

8. Asia Pacific Veterinary Intravenous (IV) Solutions Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Indication
8.2.3. By Animal type
8.2.4. By End Use
8.2.5. By Country
8.2.5.1. China Veterinary Intravenous (IV) Solutions Market Outlook
8.2.5.1.1. Market Size & Forecast
8.2.5.1.1.1. By Value
8.2.5.1.2. Market Share & Forecast
8.2.5.1.2.1. By Product
8.2.5.1.2.2. By Indication
8.2.5.1.2.3. By Animal type
8.2.5.1.2.4. By End Use
8.2.5.2. India Veterinary Intravenous (IV) Solutions Market Outlook
8.2.5.2.1. Market Size & Forecast
8.2.5.2.1.1. By Value
8.2.5.2.2. Market Share & Forecast
8.2.5.2.2.1. By Product
8.2.5.2.2.2. By Indication
8.2.5.2.2.3. By Animal type
8.2.5.2.2.4. By End Use
8.2.5.3. South Korea Veterinary Intravenous (IV) Solutions Market Outlook
8.2.5.3.1. Market Size & Forecast
8.2.5.3.1.1. By Value
8.2.5.3.2. Market Share & Forecast
8.2.5.3.2.1. By Product
8.2.5.3.2.2. By Indication
8.2.5.3.2.3. By Animal type
8.2.5.3.2.4. By End Use
8.2.5.4. Japan Veterinary Intravenous (IV) Solutions Market Outlook
8.2.5.4.1. Market Size & Forecast
8.2.5.4.1.1. By Value
8.2.5.4.2. Market Share & Forecast
8.2.5.4.2.1. By Product
8.2.5.4.2.2. By Indication
8.2.5.4.2.3. By Animal type
8.2.5.4.2.4. By End Use
8.2.5.5. Australia Veterinary Intravenous (IV) Solutions Market Outlook
8.2.5.5.1. Market Size & Forecast
8.2.5.5.1.1. By Value
8.2.5.5.2. Market Share & Forecast
8.2.5.5.2.1. By Product
8.2.5.5.2.2. By Indication
8.2.5.5.2.3. By Animal type
8.2.5.5.2.4. By End Use

9. South America Veterinary Intravenous (IV) Solutions Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Indication
9.2.3. By Animal type
9.2.4. By End Use
9.2.5. By Country
9.2.5.1. Brazil Veterinary Intravenous (IV) Solutions Market Outlook
9.2.5.1.1. Market Size & Forecast
9.2.5.1.1.1. By Value
9.2.5.1.2. Market Share & Forecast
9.2.5.1.2.1. By Product
9.2.5.1.2.2. By Indication
9.2.5.1.2.3. By Animal type
9.2.5.1.2.4. By End Use
9.2.5.2. Argentina Veterinary Intravenous (IV) Solutions Market Outlook
9.2.5.2.1. Market Size & Forecast
9.2.5.2.1.1. By Value
9.2.5.2.2. Market Share & Forecast
9.2.5.2.2.1. By Product
9.2.5.2.2.2. By Indication
9.2.5.2.2.3. By Animal type
9.2.5.2.2.4. By End Use
9.2.5.3. Colombia Veterinary Intravenous (IV) Solutions Market Outlook
9.2.5.3.1. Market Size & Forecast
9.2.5.3.1.1. By Value
9.2.5.3.2. Market Share & Forecast
9.2.5.3.2.1. By Product
9.2.5.3.2.2. By Indication
9.2.5.3.2.3. By Animal type
9.2.5.3.2.4. By End Use

10. Middle East & Africa Veterinary Intravenous (IV) Solutions Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Indication
10.2.3. By Animal type
10.2.4. By End Use
10.2.5. By Country
10.2.5.1. South Africa Veterinary Intravenous (IV) Solutions Market Outlook
10.2.5.1.1. Market Size & Forecast
10.2.5.1.1.1. By Value
10.2.5.1.2. Market Share & Forecast
10.2.5.1.2.1. By Product
10.2.5.1.2.2. By Indication
10.2.5.1.2.3. By Animal type
10.2.5.1.2.4. By End Use
10.2.5.2. Saudi Arabia Veterinary Intravenous (IV) Solutions Market Outlook
10.2.5.2.1. Market Size & Forecast
10.2.5.2.1.1. By Value
10.2.5.2.2. Market Share & Forecast
10.2.5.2.2.1. By Product
10.2.5.2.2.2. By Indication
10.2.5.2.2.3. By Animal type
10.2.5.2.2.4. By End Use
10.2.5.3. UAE Veterinary Intravenous (IV) Solutions Market Outlook
10.2.5.3.1. Market Size & Forecast
10.2.5.3.1.1. By Value
10.2.5.3.2. Market Share & Forecast
10.2.5.3.2.1. By Product
10.2.5.3.2.2. By Indication
10.2.5.3.2.3. By Animal type
10.2.5.3.2.4. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Competitive Landscape

13.1. Merck & Co., Inc.
13.1.1. Business Overview
13.1.2. Company Snapshot
13.1.3. Products & Service
13.1.4. Financials (As Reported)
13.1.5. Recent Developments
13.1.6. Key Personnel Details
13.1.7. SWOT Analysis
13.2. Dechra Veterinary Products
13.3. Sypharma
13.4. Animalcare
13.5. B. Braun SE
13.6. Woods Consulting, LLC
13.7. Baxter International
13.8. Fresenius Kabi

14. Strategic Recommendations15. About the Publisher & Disclaimer

Companies Mentioned

Merck & Co., Inc.
Dechra Veterinary Products
Sypharma Pty Ltd.
Animalcare group plc
Braun SE
Woods Consulting, LLC
Baxter International
Fresenius Kabi

Table Information

Report Attribute	Details
No. of Pages	182
Published	June 2025
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.35 Billion
Forecasted Market Value ( USD ) by 2030	$ 1.96 Billion
Compound Annual Growth Rate	6.5%
Regions Covered	Global
No. of Companies Mentioned	8

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3472EUR$3,825USD£2,924GBP €4085EUR$4,500USD£3,440GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€4244EUR$4,675USD£3,573GBP €4993EUR$5,500USD£4,204GBP